These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2210980)
41. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955 [TBL] [Abstract][Full Text] [Related]
42. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization]. Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182 [TBL] [Abstract][Full Text] [Related]
44. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury. O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295 [TBL] [Abstract][Full Text] [Related]
45. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114 [TBL] [Abstract][Full Text] [Related]
46. Oxybutynin and incontinence during grand mal seizures. Harari D; Malone-Lee JG Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301 [No Abstract] [Full Text] [Related]
47. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride. Madersbacher H; Jilg G Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781 [TBL] [Abstract][Full Text] [Related]
48. Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate. Iselin CE; Schmidlin F; Borst F; Rohner S; Graber P Br J Urol; 1997 Jun; 79(6):915-9. PubMed ID: 9202559 [TBL] [Abstract][Full Text] [Related]
49. Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride). Nagy F; Hamvas A; Frang D Int Urol Nephrol; 1990; 22(6):519-24. PubMed ID: 2093692 [TBL] [Abstract][Full Text] [Related]
50. Urodynamic variables cannot be used to classify the severity of detrusor instability. Wagg A; Bayliss M; Ingham NJ; Arnold K; Malone-Lee J Br J Urol; 1998 Oct; 82(4):499-502. PubMed ID: 9806177 [TBL] [Abstract][Full Text] [Related]
51. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence]. De Castro R; Casolari E; Ricci S Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593 [TBL] [Abstract][Full Text] [Related]
52. Management of coexistent stress and urge urinary incontinence. Karram MM; Bhatia NN Obstet Gynecol; 1989 Jan; 73(1):4-7. PubMed ID: 2909042 [TBL] [Abstract][Full Text] [Related]
53. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial. Holmes DM; Montz FJ; Stanton SL Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability. Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131 [TBL] [Abstract][Full Text] [Related]
59. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis. Schulte-Baukloh H; Mürtz G; Henne T; Michael T; Miller K; Knispel HH BJU Int; 2006 Feb; 97(2):355-8. PubMed ID: 16430646 [TBL] [Abstract][Full Text] [Related]
60. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators. Singh G; Thomas DG Neurourol Urodyn; 1995; 14(1):65-71. PubMed ID: 7742851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]